To study the effect of methyl prednisolone on post op recovery in retrograde intra renal surgery

Effectiveness of methylprednisolone on post operative recovery after retrograde intrarenal surgery (rirs) - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076882

Enrollment

Registered

2024-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Effectivenessof Methyl Prednisolone on Post Operative Recovery after Retrograde Intrarenal Surgery (RIRS): Methylprednisolone is known for its potent anti-inflammatory properties and

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients of 18-60 years of age of both gender ASA I and ASA II scheduled for elective surgery requiring general anaesthesia. 2. Patient who have solitary kidney stone 10-20mm in size

Exclusion criteria

Exclusion criteria: 1. Non consenting patient 2. Diabetic patient 3. Patients who have multiple or bilateral stones, stone diameters less than 10 and more than 20 mm, urethral stones 4. Pregnant patient 5. patient with a history of urological stone surgery in the previous 6 month 6. patient with nephrostomy catheter or Double-J stent 7. A history of urinary tract infection in the last 1 month 8. Patient with any neurological disease and taking any neuropsychiatric medication 9. Patient already on steroids

Design outcomes

Primary

Measure	Time frame
TO study the effect of methyl prednisolone on quality of recovery scoreTimepoint: Baseline(To) 10 min after (T1 ) 20 min(T2) 30 min(T3) 40min(T4) 50 min(T5) 60 min(T6) 70 min (T7) 90 min (T90) 100 min (T10) 110 min (T11) 120 min (T12)	—

Secondary

Measure	Time frame
1. Post operative quality of recovery score 2. Time for the first rescue analgesia in recovery room 3. Time for the first rescue antiemetic 4. Total analgesic consumption during the hospital stay (inj ketorolac / inj paracetamol) 5. Total antiemetic consumption (inj ondansetron) 6. To observe any side effects (Hyper glycemia , fever , any other )Timepoint: Baseline(To) 10 min after (T1 ) 20 min(T2) 30 min(T3) 40min(T4) 50 min(T5) 60 min(T6) 70 min (T7) 90 min (T90) 100 min (T10) 110 min (T11) 120 min (T12)	—

Measure

Time frame

1. Post operative quality of recovery score 2. Time for the first rescue analgesia in recovery room 3. Time for the first rescue antiemetic 4. Total analgesic consumption during the hospital stay (inj ketorolac / inj paracetamol) 5. Total antiemetic consumption (inj ondansetron) 6. To observe any side effects (Hyper glycemia , fever , any other )Timepoint: Baseline(To) 10 min after (T1 ) 20 min(T2) 30 min(T3) 40min(T4) 50 min(T5) 60 min(T6) 70 min (T7) 90 min (T90) 100 min (T10) 110 min (T11) 120 min (T12)

—

Countries

India

Contacts

Public ContactGuntesh kaur

upindermander01@gmail.com9815033776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026